Dr. Heidi Frutchy Deblock, MD

Dr. Deblock practices at MaineHealth Stephens Hospital in Norway, Maine, part of MaineHealth.

Dr. Deblock's NPI, 1922095892, was assigned on October 5, 2005. Dr. Deblock graduated from State University of New York at Buffalo School of Medicine in 1990. Dr. Deblock holds Maine license MD22762.

Dr. Deblock's primary practice is MaineHealth Stephens Hospital, at 181 Main Street, Norway, ME 04268 in Oxford County. The practice phone is (207) 743-5933.

Dr. Deblock's primary practice is MaineHealth Stephens Hospital in Norway, Maine, part of MaineHealth. Dr. Deblock is also affiliated with MaineHealth Maine Medical Center. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Dr. Deblock to 2 more medical groups and 1 hospice, each named with a free account. Dr. Deblock's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deblock practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Deblock's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Deblock's licenses on file in 2 states: Maine and New York.

CMS data shows 311 Medicare services from Dr. Deblock across 6 procedure codes in 2024, for 160 Medicare patients. Medicare paid $27,492 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Deblock in 2024. The largest group is 85 and over, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deblock's median patient age at 75, with 50% women.

In 2024, Dr. Deblock wrote 186 Medicare Part D claims for 65 patients. 79% of them were for generic drugs. CMS names the drug for 35 of them, across 3 drugs with 11 or more claims each, at $7,710 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Deblock for performance year 2024, reported through an alternative payment model (APM). Dr. Deblock accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 17 general payments to Dr. Deblock from 8 drug and device companies from 2016 to 2020. Speaker and faculty fees make up the largest share, 72% of the total. Masimo Corporation paid the most, $26,512. It also lists 1 research payment totaling $10 in 2017.

Dr. Deblock graduated from State University of New York at Buffalo School of Medicine in 1990.